Anazao Health Recalls Fentanyl Citrate and Bupivacaine HCL and Clonidine HCL
Anazao Health is recalling Fentanyl Citrate and Bupivacaine HCL and Clonidine HCL due to environmental sampling revealing a fungus.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, but the source text does not report any illnesses or injuries, and the hazard is a low-level environmental contamination (1 CFU) without reported harm, fitting the criteria for a moderate, precautionary recall.
Plain-English summary
Coast Quality Pharmacy, LLC dba Anazao Health is recalling Fentanyl Citrate and Bupivacaine HCL and Clonidine HCL in all strengths, doses, and packaging. The recall is due to a lack of processing controls and environmental sampling that identified 1 CFU (Colony Forming Unit) of Talaromyces rotundus, a fungus.
The affected products were filled and dispensed between August 26 and 29, 2019, and September 27 and October 3, 2019, and remain within their expiration dates. The products were distributed nationwide in the U.S.
Consumers should stop using the recalled products and contact their healthcare provider or pharmacist for further instructions.
The recalled product
- Product
- Fentanyl Citrate and Bupivacaine HCL and Clonidine HCL in all strengths, all doses and all packaging, AnazaoHealth 5710 Hoover Blvd Tampa, FL 33634.
- Manufacturer
- Coast Quality Pharmacy, LLC dba Anazao Health
- Category
- Drug — Pharmacy Compounded
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 31 recalled by Coast Quality Pharmacy, LLC dba Anazao Health under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 31 products in this recall →Related recalls
Same manufacturer · Coast Quality Pharmacy, LLC dba Anazao Health
See all →- HighProgesterone 200 mg compounded tablets recalled for embedded metal fragments
FDA (Drugs) · 2024-07-03
- ModerateAnazao Health Recalls Clonidine and Hydromorphone Due to Fungal Contamination
FDA (Drugs) · 2019-12-18
- SevereAnazao Health Recalls Hydromorphone, Baclofen, and Clonidine Combination Drugs
FDA (Drugs) · 2019-12-18
- SevereAnazao Health Recalls Compounded Sufentanil Syringes Due to Fungal Contamination
FDA (Drugs) · 2019-12-18
- SevereAnazao Health Recalls Baclofen, Clonidine, and Morphine Sulfate Due to Fungal Contamination
FDA (Drugs) · 2019-12-18
Same hazard · fungal contamination
See all →- SevereMedline Convenience Kits Recalled for Fungal Contamination Risk
FDA (Devices) · 2026-09-23
- CriticalMedline Convenience Kits Recalled for Potential Fungal Contamination
FDA (Devices) · 2026-09-23
- CriticalMedline Convenience Kits Recalled for Fungal Contamination Risk
FDA (Devices) · 2026-09-23
- CriticalMedline Convenience Kits Recalled for Potential Fungal Contamination
FDA (Devices) · 2026-09-23
- CriticalMedline Recalls Blood and Urine Collection Kits Due to Fungal Contamination
FDA (Devices) · 2026-09-23
Similar recalls
- SeverePharmedium Recalls Fentanyl and Bupivacaine Injections Due to Sterility Concerns
FDA (Drugs) · 2018-02-28
- HighSCA Pharmaceuticals Recalls Fentanyl and Bupivacaine Bags Due to Leakage Risk
FDA (Drugs) · 2018-07-11
- SeverePharmakon Recalls Fentanyl and Bupivacaine Bags Due to Sterility Concerns
FDA (Drugs) · 2016-07-20
- SevereCantrell Drug Company Recalls Fentanyl and Bupivacaine Bags for Sterility Concerns
FDA (Drugs) · 2016-12-21
- ModerateAdvanced Pharma Recalls Fentanyl and Bupivacaine Products for Latex Labeling
FDA (Drugs) · 2017-05-31
- SevereHartley Medical Center Pharmacy Recalls Fentanyl Citrate Syringes Due to Sterility Concerns
FDA (Drugs) · 2016-03-16